Novartis AG Long-Term Investments 2010-2024 | NVS

Novartis AG long-term investments for the quarter ending June 30, 2024 were $2.126B, a 12.62% decline year-over-year.

  • Novartis AG long-term investments for 2023 were $2.812B, a 10.1% increase from 2022.
  • Novartis AG long-term investments for 2022 were $2.554B, a 21.2% decline from 2021.
  • Novartis AG long-term investments for 2021 were $3.241B, a 74.14% decline from 2020.

Novartis AG Long-Term Investments 2010-2024 | NVS

  • Novartis AG long-term investments for 2023 were $2.812B, a 10.1% increase from 2022.
  • Novartis AG long-term investments for 2022 were $2.554B, a 21.2% decline from 2021.
  • Novartis AG long-term investments for 2021 were $3.241B, a 74.14% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$861.3B
Novo Nordisk (NVO)$592.4B
Johnson & Johnson (JNJ)$402.2B
AbbVie (ABBV)$341.7B
Merck (MRK)$299.6B
AstraZeneca (AZN)$243.5B
Pfizer (PFE)$169B
Sanofi (SNY)$144.1B
Innoviva (INVA)$1.2B